Signant Health develops new program to work more closely with CROs

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Rawpixel)
(Image: Getty/Rawpixel)

Related tags: Signant Health, CRO, eclinical

Signant Health’s new partner program was established to help reduce scope creep and prevent miscommunication between CROs and sponsors, says VP.

According to the company – formerly CRF Bracket​ – the new Signant Health Partner Program marks ‘a significant investment’ and the aim is to enable clinical research organizations (CROs) ‘to better serve sponsors,’ specifically as it pertains to patient data, patient experience, clinical supplies, and endpoint quality solutions.

“We are investing in people and streamlined processes to support CRO partners, such as increased training, scientific input, bid defense support, and ongoing governance of relationship,"​ explained Ken Billard, vice president of business development, Signant Health.

Billard added that the program was developed to strengthen the company’s CRO partnerships “to ultimately benefit sponsors.”  

Program partners will receive exclusive commercial terms, business development support, joint marketing, product training, and dedicated resources for governance, according to the company.

“Our goal is to work more closely with CROs to provide strategic planning, scientific insight, bid defense support, and comprehensive training on the Signant Health patient-centered eClinical platform to ensure our joint proposals are appropriately scoped and as comprehensive, scientifically sound, and efficient as possible,” ​Billard told us.

“By defining best practices with CROs covering the proposal process and ongoing delivery of services, we believe we can prevent miscommunication and reduce scope creep that is common when vendors work together,”​ he added.

Related news

Show more

Related products

show more

Overcoming Challenges of Clinical Data Review

Overcoming Challenges of Clinical Data Review

PerkinElmer | 10-Jun-2021 | Technical / White Paper

Clinical data review is intrinsic to clinical development, assuring patient safety, determining drug efficacy, and assessing data quality. It involves...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Related suppliers

Follow us

Products

View more

Webinars